Kushla Life Sciences

📍 Santa Rosa, United States🗓 Founded 2018👥 7 employees💰 Last funded May 2019
Biotechnology Research🌐 kushla.com
Website LinkedIn
Kushla Life Sciences is focused on driving a transition from inhalable cannabis products to fast-acting edibles, beverages, and concentrates. Read about our formulations technology in Forbes, here: bit.ly/kushlaforbes Kushla’s R.E.A.C.T. formulation has virtually no taste profile, and takes effect in about five minutes. It’s compatible with water-based and oil-based ingredients. R.E.A.C.T. is ideal for gummies, chocolates, baked good, beverages, dissolvable powder packets, pressed pills, mints, gel caps, and any other ingestible product. Kushla’s R.E.A.C.T. formulation was developed using fundamentally different technology than any other “fast-acting” formulations on the market. R.E.A.C.T. is the product of years of research and development lead by our Co-Founder, and CSO, Ramesh Chimmani, Ph.D. Kushla partners with industry leading brands to create meaningful products.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Kushla Life Sciences?
Kushla Life Sciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Kushla Life Sciences last raise funding?
The most recent investment in Kushla Life Sciences recorded on gritt.io was in May 2019.
When was Kushla Life Sciences founded?
Kushla Life Sciences was founded in 2018.
What industry is Kushla Life Sciences in?
Kushla Life Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kushla Life Sciences based?
Kushla Life Sciences is headquartered in Santa Rosa, United States.